Abdi İbrahim Pharmaceuticals, established in 1912, stands as Turkey's largest and leading pharmaceutical company. With over a century of experience, it is dedicated to 'healing lives and the world' through continuous innovation in research and development, state-of-the-art manufacturing facilities, and a broad portfolio of products. Abdi İbrahim operates in numerous international markets, exporting to over 70 countries and establishing a significant global presence. The company focuses on human health, biotechnology, and consumer health, driven by a strong ethical compass and a commitment to sustainability and societal well-being. From an end-user perspective, Abdi İbrahim is recognized for providing high-quality, accessible medicines and healthcare solutions.
The headquarters at Abdi İbrahim Tower serves as the strategic and operational core, housing corporate management, global strategy development, R&D oversight, international market coordination, and key administrative functions. It's where major decisions shaping the company's future are made.
Abdi İbrahim Tower is a modern, prominent skyscraper in Istanbul's Maslak business district. Its contemporary design likely includes advanced, eco-friendly office spaces, conference facilities, and employee amenities, reflecting the company's forward-thinking approach.
The HQ work culture is anticipated to be dynamic, collaborative, and innovation-focused, emphasizing scientific excellence, ethical conduct, and continuous learning. Employees likely experience a challenging yet supportive environment geared towards achieving breakthroughs in healthcare.
Located in Istanbul, a vital bridge between Europe and Asia, the headquarters symbolizes Abdi İbrahim's leadership in the Turkish pharmaceutical sector and its expanding global footprint. Its presence in a major financial district facilitates international business and talent attraction.
Abdi İbrahim Pharmaceuticals supports a comprehensive range of global functions including R&D collaborations, advanced manufacturing, international marketing and sales, regulatory affairs, and supply chain management. The company exports its diverse portfolio of pharmaceutical products to over 70 countries across North Africa, Asia, Europe, and the Americas. It has established direct operations, joint ventures, and strategic partnerships in key markets like Kazakhstan, Algeria, Canada, Portugal, Azerbaijan, and Bosnia & Herzegovina, enabling it to effectively serve global healthcare needs and continuously expand its international footprint.
Reşitpaşa Mahallesi, Eski Büyükdere Caddesi No:4, Abdi İbrahim Tower
Istanbul
Istanbul
Turkey
Address: Abdi Ibrahim Global Pharm LLP, Almaty region, Iliysky district, Otegen Batyr urban settlement, Industrial zone, building 210, Kazakhstan
This facility serves as a strategic production and distribution hub for the Central Asian region, enabling local manufacturing capabilities, ensuring supply chain efficiency, and strengthening Abdi İbrahim's market presence in these key emerging markets.
Address: AbdiBio Biotechnology Facility, Esenyurt, Istanbul, Turkey (Located within the main production complex area)
This state-of-the-art facility enhances Turkey's self-sufficiency in advanced biopharmaceuticals, supports Abdi İbrahim's R&D in biotechnology, and positions the company as a key player in the high-value biopharma sector both domestically and internationally.
Address: Abdi İbrahim Remede Pharma, Zone Industrielle de Oued Smar, Algiers, Algeria (Exact street address may vary, this is the industrial zone)
The Algerian plant strengthens Abdi İbrahim's presence in North Africa, allowing for localized production, adaptation to regional market needs, and contribution to the local pharmaceutical industry's development.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Abdi Ibrahim Pharmaceuticals' leadership includes:
Abdi Ibrahim Pharmaceuticals has been backed by several prominent investors over the years, including:
Public information regarding specific executive new hires or departures at Abdi İbrahim Pharmaceuticals within the last 12 months is limited, as is common for privately-held companies. The company generally maintains stability in its core leadership team. Significant C-suite changes are typically announced via official press releases or updates on their corporate website.
Discover the tools Abdi Ibrahim Pharmaceuticals uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Abdi İbrahim Pharmaceuticals most likely uses standardized corporate email formats. Common patterns for Turkish companies and international corporations include `firstname.lastname@companydomain` or `finitial.lastname@companydomain`. The specific domain is `abdiibrahim.com.tr`.
firstname.lastname@abdiibrahim.com.tr (e.g., ahmet.celik@abdiibrahim.com.tr) and finitial.lastname@abdiibrahim.com.tr (e.g., a.celik@abdiibrahim.com.tr)
Format
ayse.yilmaz@abdiibrahim.com.tr
Example
75%
Success rate
Abdi İbrahim Official Website • March 12, 2024
Abdi İbrahim announced a significant investment in a new solar power plant (SPP) at its Esenyurt Production Complex. This initiative underscores the company's commitment to sustainable production and renewable energy, aiming to substantially reduce carbon emissions and meet a large portion of the facility's energy requirements through solar power....more
Abdi İbrahim LinkedIn / Great Place to Work Turkey • February 20, 2024
Abdi İbrahim has been re-certified as a 'Great Place to Work' by the Great Place to Work Institute for the 2023-2024 period. This recognition highlights the company's ongoing dedication to cultivating a positive, supportive, and engaging work environment for its employees, reinforcing its status as an employer of choice....more
Abdi İbrahim Official Website • January 16, 2024
Abdi İbrahim emphasized its continued strong investment in Research and Development, highlighting its role as a pioneer in the Turkish pharmaceutical sector. The company's R&D center focuses on developing innovative treatments, value-added products, and new technologies, contributing significantly to the domestic pharmaceutical ecosystem and global health....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Abdi Ibrahim Pharmaceuticals, are just a search away.